µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© obO}NF*g^
k^%2_
H
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© #jBN?Z#
1¡¢Co-stimulators (or co-stimulating molecules) pLnB)z?
2¡¢NK-kB v8m`jxII64
3¡¢Immunoglobulin superfamily D^+?|Y@N
4¡¢antigen-presenting cell (APC) )1lu=gc
5¡¢death domain ^
q
?1U?4
6¡¢CCR and CXCR :_xh(W+2<
7¡¢Lectin (or mitogen) .IgRY\?Q
8¡¢Clusters of differentiation, CD) 'H|~u&?
9¡¢B7 family e"k/d<
10¡¢Cytotoxic T lymphocyte, CTL) ^2S# Uk
11¡¢IL-15 and IL-15 receptor (IL-15R) b*EXIzQ
12¡¢MHC restriction -:<lkq&/
13¡¢Affinity-chromatography /:Lu_)5
14¡¢Cyctosprin A, CsA _w!a`w*3
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) O("Uq../3
D."=k{r.
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© BI/&dKM
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Nmp
nJu|8
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ .tnkT;T
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ Elb aFbr
pf&
ag#nr
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© qf#)lyr<D6
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ (=u'sn:s
ѪҺ²¡Ñ§×¨Òµ£º pHC/(6?
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿